Projected US Savings From Biosimilars, 2021-2025
Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.
Variation in Generic Dispensing Rates in Medicare Part D
Generic use has increased over time in Medicare Part D, but substantial variation across plans persists in a number of common classes.
Insurers’ Perspectives on MA Value-Based Insurance Design Model
This article describes perspectives of Medicare Advantage (MA) insurers about participating in the CMS value-based insurance design model test launched in 2017.
Innovative Care Models for High-Cost Medicare Beneficiaries: Delivery System and Payment Reform to Accelerate Adoption
This paper illustrates how Medicare Advantage plans and accountable care organizations could benefit from adopting innovative care delivery models, and suggests policy changes to accelerate spread.
2 Clarke Drive Cranbury, NJ 08512